Literature DB >> 30827510

Cholesterol regulates cell proliferation and apoptosis of colorectal cancer by modulating miR-33a-PIM3 pathway.

Yan Wang1, Chengxin Liu2, Likuan Hu3.   

Abstract

The relationship between colorectal cancer (CRC) and cholesterol has been confirmed for many years, but the mechanism was not very clear. miR-33a was important in cholesterol metabolism and was abnormally expressed in many tumors, thus our study hypothesized that cholesterol effect on CRC by regulating miR-33a and its target gene PIM3, and verify it by series of assay. From results of CCK8 and flow cytometry, we confirmed cholesterol can stimulate CRC cell proliferation, promote cell cycle progression and inhibit cell apoptosis. miR-33a and SREBP2 mRNA expression were inhibited by cholesterol, and when cells transfected with miR-33a mimics or inhibitor the effect of cholesterol appeared a significant difference than before. In addition, PIM3 showed up-regulation with cholesterol treatment, and it was proved to be the target gene of miR-33a by dual luciferase reporter assay, it modulated CRC cells proliferation and apoptosis by phosphorylating p27, p21 and Bad protein. Thus, it inferred that cholesterol can regulate CRC development by miR-33a-PIM3 pathway.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol; Colorectal cancer; PIM3; miR-33a

Year:  2019        PMID: 30827510     DOI: 10.1016/j.bbrc.2019.02.123

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank.

Authors:  Zhe Fang; Mingming He; Mingyang Song
Journal:  Br J Cancer       Date:  2020-11-03       Impact factor: 7.640

2.  SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer.

Authors:  Yuxiao Jin; Zhiyuan Chen; Jiali Dong; Bin Wang; Saijun Fan; Xiaodong Yang; Ming Cui
Journal:  FEBS Open Bio       Date:  2021-05-01       Impact factor: 2.693

3.  Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.

Authors:  Siyu Zhou; Qian He; Nengquan Sheng; Jianfeng Gong; Jiazi Ren; Zhigang Wang
Journal:  World J Surg Oncol       Date:  2022-01-15       Impact factor: 2.754

4.  Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis.

Authors:  Yi-Yu Chen; Jing-Yu Ge; Si-Yuan Zhu; Zhi-Ming Shao; Ke-Da Yu
Journal:  Nat Commun       Date:  2022-02-10       Impact factor: 17.694

Review 5.  Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer.

Authors:  Timothy Salita; Yepy H Rustam; Dmitri Mouradov; Oliver M Sieber; Gavin E Reid
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

6.  A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.

Authors:  Anqi Feng; Lingnan He; Tao Chen; Meidong Xu
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

Review 7.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

8.  Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment.

Authors:  Jingtao Tong; Yifei Mao; Ziru Yang; Quan Xu; Zhen Zheng; Hui Zhang; Jingjing Wang; Sandian Zhang; Weibo Rong; Lu Zheng
Journal:  Cancer Manag Res       Date:  2021-05-18       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.